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Noncovalently bound complexes between basic sites of peptides/proteins and sulfonates are
studied using Matrix Assisted Laser Desorption/Ionization (MALDI) Mass Spectrometry.
Reactive sulfonate dyes such as Cibacron Blue F3G-A are known to bind to protonated amino
groups on the exterior of a protein. In this work, we examine a wide range of other sulfonates
with distinctly simpler structure and more predictable reactivity. Naphthalene-sulfonic acid
derivatives were found to bind to arginine only, as opposed to expected binding to all basic
sites (Arg, Lys and His). Detailed control experiments were designed to unambigously confirm
this selectivity and to rule out nonspecific adduct formation in the gas phase. The data show
that the number of complex adducts found equals the number of accessible arginine sites on
the surface of folded peptides and proteins, plus the N-terminus. Lys and His are not
complexed nor are buried residues with hindered access. MALDI-MS can therefore provide
fast information related to the exposed surface of these biomolecules. Additional titration
experiments with 1-anilino-naphthalene-8-sulfonic acid (ANS) revealed that this fluorescent
dye, which was often hypothesized to bind to so-called molten globule states of proteins,
behaved exactly like all other naphthalene-sulfonic acids. ANS binding thus occurs largely
through the sulfonate group. (J Am Soc Mass Spectrom 2001, 12, 810–818) © 2001 American
Society for Mass Spectrometry
Matrix-assisted Laser Desorption/Ionization(MALDI) Mass Spectrometry, introduced inthe 80s by Karas and Hillenkamp [1, 2] and
Tanaka [3], together with electrospray ionization [4, 5],
have brought mass spectrometry into biomolecular sci-
ence. Both enable mass analysis of large, polar, and
thermolabile compounds up to several hundred kDa
[6], or larger. Continous development and improve-
ment led to routine analysis of peptides and proteins [7,
8] and other natural compounds (e.g., oligonucleotides).
Further applications include tryptic digests [9] and
sequencing procedures such as protein-ladder-sequenc-
ing [10] or DNA-routines [11].
MALDI has also been used successfully in the inves-
tigation of noncovalent interactions in biomolecular
assemblies: Woods et al. detected peptide-metal ion
complexes and peptide-enzyme interactions by choos-
ing suitable conditions where sample preparation al-
lowed the macromolecular assemblies to retain their
tertiary structure [12]. Membrane-bound proteins as
well as their noncovalent aggregates, (e.g., porin in its
intact quaternary structure), have been investigated by
Rosinke et al. [13]. Limitations of matrix chemistry for a
successful desorption/ionization process and crucial
sample preparation steps have been adressed by
Glocker et al., who found 6-aza-2-thiothymine to be the
matrix of choice to detect intact noncovalent protein
complexes such as RNAse S and specific dimers of
coiled-coil leucine zipper polypeptides [14]. Analysis of
quaternary protein ensembles was presented by Cohen
and coworkers [15].
A general discussion of detecting noncovalent com-
plexes by MALDI-MS was presented by Hillenkamp
[16]. Our group has investigated noncovalent com-
plexes of dye-peptide and dye-protein complexes [17],
and successfully demonstrated the detection of specific
zinc finger peptide-oligodeoxynucleotide complexes
[18]. Most recent publications include MS-determined
models for calcium-induced folding patterns of myeloid
related proteins [19] and oligomerization as well as
substrate binding studies of adenylate kinase [20].
The work by Salih et al. [17] has shown that
MALDI-MS can be used to determine the number of
accessible basic sites of a protein or peptide in its folded
structure, by titrating them with the reactive sulfonate
dye Cibacron Blue F3G-A. Protonated amino acid resi-
dues on the surface of the biomolecules form noncova-
lent complexes with the deprotonated part of the sulfo-
nate dye (Figure 1).
Probing the accessible Arg, Lys, and His residues on
Published online May 8, 2001
Address reprint requests to Dr. Renato Zenobi, Department of Chemistry,
Swiss Federal Institute of Technology, ETH Zentrum CHN C59, Universi-
ta¨tstrasse.16, CH-8092 Zurich, Switzerland. E-mail: zenobi@org.chem.
ethz.ch
© 2001 American Society for Mass Spectrometry. Published by Elsevier Science Inc. Received November 20, 2000
1044-0305/01/$20.00 Revised March 2, 2001
PII S1044-0305(01)00257-4 Accepted March 2, 2001
the surface of proteins is important because they often
play a crucial role in protein recognition. Let us take
arginine as an example to illustrate this: chorismate
mutase (CM, a key enzyme in the biosynthesis of
aromatic amino acids) of bacillus subtilis shows two
essential arginine residues in its catalytic site [21], the
CM of E. coli even uses three arginines out of seven
total to fulfill its enzymatic task [22]. The fundamental
role of arginine in the catalytic triade of serine proteases
[23] such as trypsine also supports the statement above.
Chemical controls such as exclusion experiments or
chemically modified substrates (e.g., point mutations or
introduction of protecting groups) generally are key to
determine the specificity of noncovalent interactions
[24]. Chemically controllable factors need to directly
influence the outcome of the MS data; otherwise that
data does not reflect the investigated system properly.
This paper deals with noncovalent complexes be-
tween amino acid residues of peptides/proteins (rang-
ing in mass from 1.2 to 13 kDa) and low molecular
weight sulfonic acids. We examined a wide range of
sulfonates with distinctly simpler structure and more
predictable reactivity than in earlier work. Interestingly,
those simpler compounds (e.g., naphthalene-1,5-disul-
fonic acid) were found to bind to arginine only, as
opposed to expected binding to all basic sites (Arg, Lys
and His). We present detailed control experiments to
confirm this by employing chemically modified sub-
strates and sequence-specific substitutions, respec-
tively. Further, we employ a dry mixing sample prep-
aration technique that avoids mixing analyte and
sulfonate in the same solvent. Using this technique, we
were able to show that the detected noncovalent com-
plexes are really pre-formed prior to the desorption step
and that our data is not the consequence of unspecific
gas phase adduct formation. In other words, these
MALDI experiments do reflect condensed phase chem-
istry.
This work includes titration experiments with ANS,
a fluorescent dye for probing hydrophobic sites on the
surface of partially unfolded proteins [25]. Detection of
so-called molten globule states [26] of proteins by
fluorescence spectroscopy using ANS is widely used in
protein folding/unfolding studies: a literature search
for the terms ANS and molten globule yielded over 100
references published in the last five years (for some
examples, see [27–29]). The binding mode between ANS
and proteins has rarely been investigated. This topic has
recently led to a controversial discussion in the litera-
ture: ANS is generally believed to probe hydrophobic
sites (tryptophan, tyrosine) of partially unfolded pro-
teins, mainly binding to conformations at a pH where
the biomolecules are found in molten globule states.
However, recent work indicates that ANS instead forms
noncovalent complexes via its sulfonate group. Ali et al.
have compared the hydrophobic characteristics of ANS
to those of a non-sulfonic acid derivative (nile red) [30].
They showed that ANS, as a charged hydrophobic dye,
induces partial protein unfolding and forms complexes
with the biomolecules, while under similar conditions
no complex formation can be observed with using nile
red. Matulis and Lovrien have reported that the ANS2
anion dominantly binds to cationic groups of proteins
through ion-pair formation [31]. They demonstrate that
binding to a number of proteins occurs through the
ANS sulfonate group. Recent electrospray-ionization
(ESI) mass spectrometry studies have further confirmed
these results [32, 33]. In our own titration experiments,
ANS was found to behave exactly like all other naph-
thalene-sulfonic acids, thus argueing against the hydro-
phobic binding mode.
Experimental
Mass Spectrometry
All mass spectra were obtained using a home-built 2 m
linear time-of-flight mass spectrometer. The mass reso-
lution of this instrument is only ;200, but this was
sufficient to resolve all adducts. Desorption and ioniza-
tion of the samples was performed using the 337 nm
output from a pulsed nitrogen laser (model VSL-337
ND-T, pulse width 5 3 ns, Laser Science Inc., Franklin,
MA). The nitrogen laser was focused onto the sample
surface forming an elliptical spot of 0.1 mm 3 0.2 mm.
Laser pulse energies were in the range of 20–60 mJ; an
acceleration potential of 26 kV was used in the source
Figure 1. Principle of titration of basic amino acid residues by
sulfonates. In this protein, histidine cannot interact with a sulfo-
nate group because it is not exposed on the surface, but rather
buried within the tertiary structure.
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region for ion extraction. Ions were detected with a pair
of microchannel plates, and the signal was acquired on
a 500 MHz (LeCroy 9450, MA) digital oscilloscope. Each
waveform was passed to a personal computer for
further processing. The acquisition was triggered by the
laser pulse via a photodiode. To improve the signal/
noise ratio, a minimum of 80 single spectra were
collected and averaged. The data are presented without
further smoothing. All spectra shown in this paper have
been acquired in the negative ion mode. We have
obtained similar results for positive ion mode as well,
but the signal-to-noise ratio in negative ion mode was
superior.
Sample Preparation
Spectra were acquired using 4-nitroaniline (4NA, 1022
M in ethanol) as a non-acidic MALDI matrix. For one
experiment, ferulic acid (0.1 M in water-acetonitrile, 1:1
v/v) was used as an acidic matrix. All of the analyte
and sulfonate solutions were prepared in water with
concentrations of 1024 and 1023 M, respectively.
MALDI samples were prepared by mixing the analyte
and sulfonate with the matrix solution (1:1:2 v/v/v),
yielding a solution at neutral pH. A total of 1.5 mL of
this mixture was deposited on the probe tip, rapidely
dried in vacuo and then analyzed. For a denaturation
experiment, ubiquitin was incubated for 3h in a 1:3
mixture of water/methanol containing 2% acetic acid.
For solid phase control experiments, matrix-analyte and
matrix-sulfonate solutions were dried separately in a
rotatory evaporator and the resulting powders were
mixed without the use of any solvent. The powder
mixture was then affixed to the probe tip using double-
sided adhesive tape.
Materials
Luteinizing hormone releasing hormone, [D-Lys6]-lu-
teinizing hormone releasing hormone, [Ac-D-Trp1, D-p-
Cl-Phe2, D-Trp3, D-Arg6, D-Ala10]-luteinizing hormone
releasing hormone, adrenocorticotropic hormone (frag-
ments 1–10), melittin, gastroinhibitory polypeptide (hu-
man and porcine), insulin, ubiquitin, cytochrome c,
ferulic acid and 4-nitroaniline were obtained from
Sigma (Buchs, Switzerland). 1-anilino-naphthalene-8-
sulfonic acid, anthraquinone-2-sulfonic acid, 6-amino-1-
naphtol-3-sulfonic acid, bombesin, Cibacron Blue F3GA,
1-naphtylamino-5-sulfonic acid, naphthalene-2-sulfonic
acid, naphthalene-1,5-disulfonic acid, naphthalene-1,3,6-
trisulfonic acid and sulfanilic acid were obtained from
Fluka (Buchs, Switzerland). To remove sodium and
potassium ions, desalination of the sulfonate solutions
was performed using the drop dialysis method [34]. All
reagents were of highest purity available and solvents
were of spectrophotometric grade. Polypeptides and
proteins were purchased as lyophilized solids and
stored below 24 °C. Aqueous solutions were prepared
using nanopure grade water. Abbreviations of all com-
pounds are used as referenced in Table 1.
Results and Discussion
Our group has successfully used Cibacron Blue F3G-A
(CCB) for titration experiments [17]. The interaction
between dye molecules and proteins in the gas phase
was found to be electrostatic, and all positively charged
groups (Arg, Lys, His plus N-terminus) on the exposed
surface of the biomolecules were complexed by the
titrating agent. Furthermore, the data obtained showed
that the distance between two residues played a role: if
they were too close to each other, Coulombic repulsion
limited the number of positive charges (e.g., the case of
two lysines in direct neighbourhood in the peptide
sequence of melittin).
We verified these findings by choosing the insulin/
CCB system. Besides the protonated molecular ion
signal (m/z 5 59734) there are five CCB adducts in total
(Dm/z 5 773 for the free acid), reflecting five basic sites.
All of the basic amino acid residues (one arginine and
two histidines) are located in the b-chain and are quite
far from each other. Steric hindrance will thus be minor.
Insulin consists of two polypeptide chains linked to-
gether via disulfide bonds and a salt bridge between the
Table 1.
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N-terminus of the a-chain and the C-terminus of the
b-chain. This ionic interaction is probably not disrupted
during MALDI sample preparation, such that the ex-
pected number of adducts adds up to five (1 Arg, 1 Lys,
2 His, 1 free N-terminus) in perfect agreement with the
mass spectrum [17].
Table 1 lists the accessible basic residues exposed on
the surface of the peptides and proteins in their folded
form and thus the expected number of adducts for the
systems chosen. Anthraquinone-sulfonic acid (ACS)
and aminonaphtol-sulfonic acid (AOS) were both of
interest to us because they resemble several parts of
CCB’s structure. Unfortunately, both compounds were
completely insoluble in water even after extended ul-
trasonication. Aminonaphtyl-sulfonic acid (AYS) and
sulfanilic acid (SLS) formed an extensive number of
nonspecific adducts with the matrix 4-nitroaniline
(4NA) to yield clusters over a broad mass range, so
these compounds were excluded as well. We also tried
to detect complexes of melittin with SLS in the absence
of any MALDI matrix, by gradually increasing the
relative concentration of SLS while decreasing that of
4NA. Signals corresponding to peptide-dye adducts
were never observed, and peptide signals were only
observed if the matrix concentration was high enough.
This behavior shows that SLS itself is not acting as a
MALDI matrix. Finally, the compounds of choice were
mono-, di- and trisulfonated naphthalenes, all being
readily soluble in water. Free acids were obtained by
ion exchange as outlined in the experimental section.
In 4NA as well as in ferulic acid solutions, Arg, Lys
and His all carry a positive charge, while sulfonates are
deprotonated. 4NA was not chosen because it is a
non-acidic MALDI matrix (other matrices would
equally maintain the charge states of complexing part-
ners), but because it allows the proteins to be as close as
possible to the native state [35]. Figures 2 and 3 present
the negative ion mode MALDI mass spectra of several
peptides/proteins in the presence of mono- and disub-
stituted sulfonic acid derivatives of naphthalene, re-
spectively. For details refer to the figure captions.
The experimentally found number of adducts does
not correspond to the total number of all basic sites.
Surprisingly, relative signal intensities differ dramati-
cally for the investigated systems and there is no
regular signal distribution pattern: insulin and cyto-
chrome c exhibit a decreasing intensity of the higher
adducts, whereas melittin shows a bell-shaped distribu-
tion. In our experiments, the molar ratio of peptides
versus sulfonates is kept constant at 1:10 (peptide:
sulfonate) and thus cannot have caused these different
distribution patterns.
Noncovalent complexes of peptides/proteins and
naphthalene-trisulfonic acid (NTS) were also investi-
gated; the resulting negative ion MALDI mass spectra
are shown in Figure 4. Apparently, two peptides (M)
can react with the same NTS molecule (D), as evidenced
by the observation of the 2M 1 D complex for all
systems.
Triple complex assemblies of the 3M 1 D type, how-
ever, were never observed. Up to two peptide mole-
cules, but not more, can thus attach to one NTS mole-
cule. This is probably due to Coulombic repulsion
(three negative charges on a small molecule), and also
steric hindrance, which prevents three peptides from
binding to the relatively small NTS molecule simulta-
neously.
Arginine Selectivity
After investigating a large number of complexes be-
tween peptides/proteins and sulfonates, it became clear
that for no single system the number of noncovalent
sulfonate adducts corresponded to the sum of all basic
sites. Nevertheless, a systematic pattern was found
(Table 1): in every case, the number of adducts in the
mass spectra seemed to correlate with the number of
Figure 2. Negative ion mode MALDI mass spectra of bombesin
(a) and insulin (b) with NMS. M represents bombesin or insulin
and D represents NMS as the free acid. The data was obtained
using 4NA as matrix. A total of 2 NMS-adducts can be identified
in both spectra (weak additional signals result from nonspecific
matrix adducts).
Figure 3. Negative ion mode MALDI mass spectra of bombesin
(a), melittin (b), insulin (c) and cytochrome c (d) with NDS. M
represents the biomolecule and D represents NDS as the free acid.
The data was obtained using 4NA as matrix. The number of
NDS-adducts corresponds to the number of arginine residues plus
one for the N-terminus (see Table 1, weak additional signals result
from nonspecific matrix adducts).
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arginine residues plus the N-terminus. To test this
hypothesis, we developed several control experiments.
Does the concentration of the sulfonate solution influ-
ence our results? In such cases, the number of adducts
would depend on the relative molar ratio between
analyte and sulfonate. If the concentration of sulfonate
is increased, more adducts might be detected because
more potentially basic sites can be complexed. On the
other hand, by lowering the concentration a lot, not all
possible complexes may be formed. In our experiments,
we normally use a ten-fold molar excess of sulfonate
(1023 M) over the analyte (1024 M). By probing a
concentration range of 1025 M up to 1021 M of sulfonate
while keeping the analyte concentration constant at
1024 M, we found no additional adduct signals to arise
for the system melittin/NDS/4NA (data not shown).
However, very low concentrations resulted in ex-
tremely low signal intensities and/or partial loss of
peaks. Choosing a ten-fold molar excess, we thus can
safely rule out any concentration effects.
By far the most powerful control is derived from
chemical modification. Lowe and coworkers have in-
vestigated protein-dye interactions, mainly studying
the Cibacron Blue dye and related structures [36]. They
were the first to demonstrate the strong affinity of
sulfonates to positively charged guanidino groups, and
probed their electrostatic interaction and steric hin-
drance after chemically substituting the guanidino- for
a trimethylammonium-group.
We decided to choose a bioactive peptide that is
commercially available in different modifications and
found luteinizing hormone releasing hormone (LH-RH)
to be well suited for this purpose. LH-RH consists of ten
amino acids and has 1 Arg and 1 His in its sequence; we
thus expect two adducts in the mass spectrum (one for
arginine and one for the N-terminus). In [D-Lys6]-LH-
RH (LH-RH-1K), a non-basic amino acid is replaced
with Lys at position 6; according to our theory, this
should not increase the number of adducts, as Lys is not
expected to form complexes. Finally, the third modifi-
cation, [Ac-D-Trp1, D-p-Cl-Phe2, D-Trp3, D-Arg6,
D-Ala10]-LH-RH (LH-RH-1Ac-1R), has an acetylated
N-terminus and an additional arginine residue, while
all other amino acids are replaced by non-basic ones.
From the sequences, we postulate that all three mass
spectra should show the same number of signals, one
for the molecular ion peak and two for noncovalent
complex adducts.
The data fully confirms our hypothesis (Figure 5). All
three spectra show two adducts—the additional Lys
does not influence the number of adducts, and the
acetylated N-terminus no longer forms a noncovalent
complex. Relative signal intensities are very similar in
Figure 4. Negative ion mode MALDI mass spectra of ACTH
F1-10 (a), bombesin (b), melittin (c) and insulin (d) with NTS. M
represents the biomolecule and D represents NTS as the free acid.
The data was obtained using 4NA as matrix. There are no more
signals above the mass range shown.
Figure 5. Negative ion mode MALDI mass spectra of LH-RH (a),
LH-RH-1K (b) and LH-RH-1Ac-1R (c) with NDS. M represents
LH-RH and its modifications and D represents NDS as the free
acid. The data was obtained using 4NA as matrix. A total of 2
NDS-adducts can be identified in the three spectra; they all reflect
specific complexation of arginine residues and the N-terminus
(weak additional signals result from nonspecific matrix adducts).
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all three spectra. The noncovalent 1:1 peptide-sulfonate
complex shows the most intense signal, whereas the 1:2-
assembly exhibits a weaker intensity.
To go beyond the peptide mass range, we carried out
another control experiment with two modified proteins.
Our prerequisite was a molecular weight of $49000 Da
to ensure a real and known tertiary structure, know-
ledge of the full amino acid sequence and the existence
of Arg, Lys and His in this sequence. The gastroinhibi-
tory polypeptide GIP (MW ; 59000 Da) meets all our
requirements. GIP is commercially available in two
modifications and their two sequences differ in exactly
one amino acid residue: His18 in human GIP (GIP-1H) is
replaced by Arg18 in porcine GIP (GIP-1R). The helical
structure of both modifications [37] guarantees full
accessibility to all residues, so steric hindrance will be of
minor importance. Both proteins are stable under com-
mon MALDI experimental conditions and are easy to
ionize. If our assumption of arginine selectivity is
correct, we expect GIP-1R mass spectra to show two
adducts, while GIP-1H should only form one sulfonate
adduct.
Figure 6 presents the experimental findings. They
also agree with our hypothesis: the weak additional
signals are not due to complex formation with the
sulfonate but result from nonspecific matrix adducts.
The experiments with LH-RH and GIP demonstrate
the selectivity of sulfonate derivatives for arginine
residues of selected peptides and proteins. Mass spectra
of our systems can in principle be predicted from amino
acid sequence and 3-D structure information. On the
other hand, the phenomenon can be used to determine
the number of arginines of new proteins. Of course,
only arginines exposed on the surface of the folded
protein will be probed and therefore complexed. Resi-
dues that are buried within the folded biomolecule will
not form noncovalent complexes, because they are not
accessible for this kind of interaction. A complementary
strategy has been used by Przybylski and coworkers
[38]: they covalently modified lysine and arginine resi-
dues and were able to identify the modified residues
using peptide mapping upon denaturation of the inves-
tigated model protein. Similarly, the total number of
arginines can only be determined with our method
upon full unfolding of the protein.
We have carried out a denaturation experiment with
ubiquitin, as this protein will expose additional arginine
residues upon denaturation. Katta and Chait observed
conformational changes in ubiquitin by proton ex-
change ESI mass spectrometry [39]. According to these
authors, only Arg74 and Arg72 are clearly exposed to the
solvent. Arg54 may be only partially exposed to the
solvent [17]. Figure 7 shows the mass spectrum of
ubiquitin before and after denaturation. We find 2–3
noncovalent complexes for folded ubiquitin with NDS,
so up to 2 exposed arginine residues are complexed; the
third adduct (corresponding to the N-terminus) is of too
low intensity to clearly be identified. After three hours
incubation in a 1:3 mixture of water-methanol contain-
ing 2% acetic acid, the MALDI spectrum of freshly
denatured ubiquitin reveals 4–5 adducts, so previously
inaccessible arginine residues are titrated as well.
The denaturation experiment allows some interest-
ing conclusions. Ubiquitin retains a folded conforma-
tion in the gas phase, where the same number of basic
residues is exposed as for the native state, even after
being subjected to MALDI sample crystallization and
desorption/ionization steps. This is not meant to indi-
cate that the protein is in its native form in the gas
phase, as other interactions stabilizing a native confor-
Figure 6. Negative ion mode MALDI mass spectra of GIP-1R
(upper) and GIP-1H (lower) with NDS. Peak series are assigned to
(M 1 nD 2 H)2, where M represents the GIP-modification, and D
represents NDS as the free acid. The data was obtained using 4NA
as matrix. The two systems differ by one sulfonate adduct (weak
additional signals result from nonspecific matrix adducts).
Figure 7. Negative ion mode MALDI mass spectrum of ubiquitin
—NDS complexes in 4NA, before (a) and after (b) denaturation of
ubiquitin using a 1:3 mixture of water-methanol containing
2% acetic acid. In these spectra, peak series are assigned to
(M 1 nD 2 H)2, where M represents ubiquitin and D respresents
NDS as the free acid.
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mation, such as hydrophobic interactions, will certainly
be much less important or even completely absent in
the gas phase.
However, chemical changes (in this case denatur-
ation) carried out in the condensed phase are fully
reflected in the mass spectral data: upon denaturation,
buried arginine residues become accessible to complex
formation with sulfonate moieties. This indeed indi-
cates that the protein has changed its shape from a
higher order structure to a completely accessible and
barely structured molecule.
We believe that the detected sulfonate adducts are
preformed in the condensed phase and hence reflect
solution phase chemistry and that our data is not the
consequence of post-desorption reactions. Many publi-
cations have discussed nonspecific gas phase adduct
formation, but relatively little effort has been made to
truly demonstrate that the formation of noncovalent
complexes really takes place in solution prior to desorp-
tion [40]. We therefore designed a control experiment to
rule out gas phase formation of nonspecific adducts:
lyophilized melittin was dissolved in an aqueous matrix
solution of 4NA and crystalline NDS was dissolved in a
solution of 4NA in methanol, respectively. Both mix-
tures were dried separately in a rotatory evaporator and
the resulting yellow powders were mixed without the
use of any solvent. The mixture was then attached to the
probe tip using double-sided adhesive tape, but no
pressure was applied (i.e., no pellets were pressed).
Molar ratios used for the different components were
comparable to the other experiments. Low laser power
was used, in order to minimize the amount of particles
ejected from the sample to avoid unnecessary contam-
ination of the MALDI source. Spectra obtained from
such samples are of much lower quality than usual.
Nevertheless, the information obtained is easy to inter-
pret: Figure 8 presents negative ion mode MALDI mass
spectra of melittin and NDS in a 4NA matrix.
In Figure 8a analyte and sulfonate were not cocrys-
tallized, so noncovalent complexes cannot form in so-
lution. This spectrum shows no NDS adducts at all,
proving that the complexes are not formed in the gas
phase. A 1 ml droplet of methanol was then added to the
sample and a mass spectrum was again measured
(spectrum b). By adding solvent, analyte and sulfonate
can react for a short period within the same solvent and
then cocrystallize on the same probe tip: by now, at
least two of three expected adducts can be identified in
the spectrum (Figure 8b). A total of three adducts would
have been expected for the melittin/NDS system, but as
we were not able to fully control the stoichometry, we
only conclude that adducts are formed.
We additionally carried out titration experiments
with 1-anilino-naphthalene-8-sulfonic acid (ANS), and
have found the dye to behave exactly like all other
naphthalene-sulfonic acids, as indicated in the mass
spectra (Figure 9). This data has been obtained using
ferulic acid (pH ’ 3–4). Obviously, this weakly acidic
matrix, like 4NA, is able to keep the peptides/proteins
in a near native/non-denatured state, (i.e., a non-acidic
matrix environment does not seem to be critical in a
rapid MALDI sample preparation).
Noncovalent binding of ANS in solution largely
occurs through the sulfonate group, and the detected
adducts reflect the number of accessible arginine sites
plus N-terminus. Thus, our results support the inter-
pretation of Ali and coworkers [30] who questioned the
conclusion that ANS detects partially folded protein
intermediates, especially those observed under lowered
pH conditions (e.g., molten globule states).
Figure 8. Negative ion mode MALDI mass spectrum of the
melittin/NDS system in a 4NA matrix by choosing a non-cocrys-
tallizing sample preparation technique: (a) Dried samples of
analyte/matrix- and sulfonate/matrix-mixtures were placed on
the probe tip by mixing the powders without addition of any
solvent. (b) The same sample on the same tip, after addition of 1
ml methanol and recrystallization.
Figure 9. Negative ion mode MALDI mass spectra of ACTH
F1–10 (a), bombesin (b), melittin (c) and insulin (d) with ANS. In
these spectra, peak series are assigned to (M 1 nD 2 H)2, where
M represents the biomolecule and D represents ANS as the free
acid. The data was obtained using a ferulic acid matrix. The
number of ANS-adducts corresponds to the number of arginine
plus N-terminus (weak additional signals result from nonspecific
matrix adducts).
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Why Arginine?
Noncovalent interactions comprise ionic interactions,
hydrogen-bonding, hydrophobic- as well as van der
Waals-interactions. In the case of protonated basic
amino acid residues and deprotonated sulfonates, the
interaction is normally explained in terms of ionic
interactions [17]. At this point, the selectivity of simple
sulfonate compounds for arginine is not fully under-
stood. Among all amino acids, arginine has by far the
highest gas phase basicity [41] and the highest pKA-
value (pKA 5 12.48 for the guanidino group [42]), giv-
ing a possible explanation for preferential arginine
selectivity of sulfonates (typical pKA ,, 0 [43]) over
other basic amino acids. The principal arginine-sulfon-
ate interaction is a salt bridge, however, enhanced by
ion-dipole interactions and hydrogen bonds that are
especially favorable because of the near-perfect shape
complementary of the two bidentate binding partners.
Noncovalent complexes were detected with the proton-
ated N-terminus (average pKA-values 5 9.1-10.6 [43])
of peptides/proteins, but neither with lysine (pKA 5
10.54 for «-NH3
1 [42]), nor with histidine, which is only
weakly basic (pKA 5 6.04 for the imidazole group [42]).
This discrimination of lysine versus N-terminus defi-
nitely questions the interaction between sulfonates and
protonated residues to be of purely electrostatic nature.
For the complexation of a protein’s N-terminus, we also
believe that ion-dipole interactions including additional
hydrogen bonds contribute to the interaction. Work on
these issues is still in progress.
The somewhat special role of arginine in noncova-
lent interactions has been observed before: in 1994,
Juhasz and Biemann had found that highly acidic
biomolecules such as suramin are readily ionized in a
MALDI process after addition of a basic polypeptide to
form a noncovalent complex [44]. Suramin is a drug
containing two trisulfonated naphthalene moieties and
therefore fairly close to our own investigations. The
authors demonstrated that the extent of complex forma-
tion is correlated with the number of sulfonate groups
in the acidic component and with the number of argi-
nines in the basic component. Neither the acidic amino
acid residues aspartic and glutamic acid nor the basic
lysine or histidine residues contributed to complex
formation and thus, did not influence the experimental
results. The authors provided several application exam-
ples of the phenomenon, but did not adress the question
of why their sulfonated compounds should exhibit a
special interaction with arginine, but not with the other
residues.
We could also consider the special reactivity of the
Cibacron Blue dyes: for several decades, the interaction
between CCB and proteins has been of interest. Immo-
bilised sulfonate reactive dyes are widely used for
dye-ligand affinity chromatography of proteins [45];
CCB shows affinity to a broad range of enzymes.
Biellmann et al. [46] have published the crystal struc-
ture of CCB-bound horse liver alcohol dehydrogenase
(ADH). Lowe et al. have used these data to investigate
the interaction of CCB and ADH in more detail [47]:
they found that different parts in the molecular struc-
ture of CCB exhibited completely different reactivities,
except for two of the sulfonate groups. The terminal
sulfonate group as well as the sulfonate group in the
linking diaminobenzene-unit were found to always
interact with two arginine residues of ADH. Ten years
ago, Burton and coworkers [36] considered the role of
the third sulfonate group bound to the anthraquinone-
system. Too close proximity to the amino group inhibits
a strong sulfonate dye-protein interaction. Burton also
demonstrated the strong affinity of sulfonates to posi-
tively charged guanidino groups; almost no affinity
between dye and protein remained after substitution of
the guanidino- to a trimethylammonium-group.
Interestingly, chemical control experiments includ-
ing modifications (e.g., methylation, acetylation, etc.)
have rarely been carried out. In our work, simple
organic chemistry such as protected N-termini or sub-
stitution of amino acids was employed to design control
experiments. These chemical controls are by far the
most powerful tools to answer questions about speci-
ficity and for confirming whether MS does reflect the
assumed biochemical situation or not.
Conclusions
Noncovalent complexes between arginine residues of
peptides/proteins and naphthalene-based sulfonates
employing MALDI mass spectrometry have been suc-
cessfully detected. In contrast to reactive dyes such as
Cibacron Blue F3G-A, these simpler compounds exclu-
sively formed complexes with arginine residues and the
N-terminus. Other basic sites such as lysine or histidine
were not complexed. Titration experiments with 1-ani-
lino-naphalene-8-sulfonic acid (ANS) gave exactly the
same results: ANS binding thus preferentially occurs
through its sulfonate group. The use of 4-nitroaniline
allowed the investigated peptides and proteins to retain
a folded structure. Detailed chemical control experi-
ments involving amino acid substitution and the addi-
tional use of denaturating conditions unambigously
confirmed selectivity for arginine. We also prove that
our data is not the result of post-desorption gas phase
reactions, but reflects condensed phase chemistry.
The results as well as literature data show that the
phenomenon of selective titration of arginine residues
by sulfonates is not at all unusual. However, this
phenomenon is still not fully understood; it seems that
peptide/protein–sulfonate interactions are due to hy-
drogen-bonds or more generally speaking due to ion-
dipole interactions.
Potential applications of our work are in fields where
rapid structural screening of large numbers of peptides
or proteins is needed, such as genetic- and protein-
engineering applications or large-scale synthesis of non-
bacterial proteins [48, 49]. Structural screening methods
or rapid validation for such systems are still being
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developed—probing basic sites by MALDI-MS tech-
niques might offer a fast and inexpensive alternative.
Finally, the whole concept could be reversed to probe
exposed acidic sites on the surface of folded peptides
and proteins by employing tertiary or quaternary am-
monium groups.
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